South Street Advisors LLC Novo Nordisk A S Transaction History

South Street Advisors LLC

$652 Million
Q4 2024

A detailed history of South Street Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, South Street Advisors LLC holds 167,161 shares of NVO stock, worth $14.7 Million. This represents 2.21% of its overall portfolio holdings.

Number of Shares

167,161

Previous 186,531 10.38%

Holding current value

$14.7 Million

Previous $22.2 Million 35.26%

% of portfolio

2.21%

Previous 3.38%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$85.0 - $120.04 $1.65 Million - $2.33 Million	-19,370 Reduced 10.38%	167,161 $14.4 Million
Q3 2024 Nov 06, 2024	SELL	$119.07 - $145.42 $5.36 Million - $6.54 Million	-44,988 Reduced 19.43%	186,531 $22.2 Million
Q2 2024 Aug 07, 2024	SELL	$122.71 - $146.91 $393,776 - $471,434	-3,209 Reduced 1.37%	231,519 $33 Million
Q1 2024 May 10, 2024	SELL	$102.11 - $135.92 $520,658 - $693,056	-5,099 Reduced 2.13%	234,728 $30.1 Million
Q4 2023 Feb 14, 2024	SELL	$87.78 - $105.45 $82,776 - $99,439	-943 Reduced 0.39%	239,827 $24.8 Million
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $11 Million - $24.2 Million	121,406 Added 101.71%	240,770 $21.9 Million
Q2 2023 Aug 11, 2023	SELL	$155.98 - $172.65 $5.18 Million - $5.74 Million	-33,239 Reduced 21.78%	119,364 $19.3 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $12,439 - $14,959	94 Added 0.06%	152,603 $24.3 Million
Q4 2022 Feb 06, 2023	SELL	$102.55 - $135.33 $395,637 - $522,103	-3,858 Reduced 2.47%	152,509 $20.6 Million
Q3 2022 Nov 03, 2022	SELL	$95.28 - $116.93 $224,384 - $275,370	-2,355 Reduced 1.48%	156,367 $15.6 Million
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $6.85 Million - $8.08 Million	66,305 Added 71.75%	158,722 $17.7 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $8.6 Million - $10.4 Million	92,417 New	92,417 $10.3 Million

Others Institutions Holding NVO

# of Institutions

1,881

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $199B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of South Street Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on South Street Advisors LLC with notifications on news.

Account

South Street Advisors LLC Novo Nordisk A S Transaction History